6July - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe microbiome has gained a lot of attention over the past decade from scientists to understand how microorganisms residing in human bodies can influence their physiological and psychological health. On this front, the latest developments, technologies, and resources are revolutionizing the microbiome research arena. New culturing technologies are facilitating mechanistic studies of difficult-to-culture gut microbes. A number of previously uncultivable microbes are now cultivable as a result of these advancements, providing insight into community dynamics and network interactions.On the other hand, stem cell technologies and tissue engineering allow for the construction of organoids capable of facilitating cost-effective, high-throughput microbiome studies. Besides, modulation of the gut microbiota is emerging as an effective method to delineate the composition and function of microbial communities, providing new ways to prevent and treat disease. In this edition of Pharma Tech Outlook, we present to you the story of the New Hampshire-based Boston Analytical. The company provides testing services, including protein chemistry studies, microbiological testing, stability testing and ICH-compliant storage, and extractables and leachables studies to pharmaceutical and medical device companies worldwide. Likewise, this edition brings you some of the most prominent organizations that specialize in providing microbiome solutions and services. Besides, the magazine also offers a combination of thought leadership from subject matter experts with real-life stories on fostering robust partnerships and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the microbiome solutions and services providers according to your requirements.Let us know your thoughts! Ushering a New Era of Microbiome Studies Copyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JULY - 13 - 2020, Vol 06 - Issue 14 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Jaxon JaseTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >